person
Sebastian O.
- Country
- Germany
- Department
- Charité Comprehensive Cancer Center
Research Overview
assignment
32
Clinical Trials ·
- Phase I Study of IMA401 TCER® in Patients with Solid Tumors: Monotherapy and Combination with Checkpoint Inhibitor
- Phase I Evaluation of FS222 for Safety and Efficacy in Patients with Advanced Malignancies
- Evaluation of KO-2806 as Monotherapy and in Combination Therapies for Advanced Colorectal, NSCLC, Pancreatic, and Renal Cell Carcinomas
location_city
2
Research Sites
Data & Insights
medical_services
Primary Speciality
Main therapeutic area
handshake
Return Partnerships
Recurring site collaborations
138
Sites with multiple studies
Has run more than one trial at 138 of 316 partner sites.
Specializations
Primary Oncology Focus
The investigator specializes in treating advanced solid tumors with particular emphasis on non-small cell lung cancer and head and neck squamous cell carcinoma.
- Thoracic Oncology
- Head and Neck Cancer
- Gastrointestinal Malignancies
Therapeutic Approaches
Expertise in novel therapeutic strategies including immunotherapy combinations and targeted antibody-drug conjugates for treating resistant cancers.
- Immunotherapy
- Bispecific Antibodies
- Precision Medicine
Research Interest Areas
Focus on treating metastatic disease and developing therapies for refractory cancers. Special interest in biomarker-driven treatment approaches.
- Drug Resistance Mechanisms
- Biomarker Development
- Novel Combination Strategies
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.